Log In
Print
BCIQ
Print
Print this Print this
 

ch14.18 (APN311)

  Manage Alerts
Collapse Summary General Information
Company Apeiron Biologics AG
DescriptionChimeric monoclonal antibody (mAb) against GD2
Molecular Target GD2
Mechanism of ActionAntibody
Latest Stage of DevelopmentPhase III
IndicationBrain cancer
Partner

Paladin Labs Inc.
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today